StreetInsider.com Pre-Open Movers 10/04
StreetInsider.com Pre-Open Movers:
Hollis-Eden Pharmaceuticals, Inc. (NASDAQ: HEPH) 41% HIGHER; announced positive new preclinical data with its drug candidate HE3235 for the treatment of cancer.
Penwest Pharmaceuticals Co. (Nasdaq: PPCO) 28% LOWER; the company and Endo Pharmaceuticals (Nasdaq: ENDP) received a notice from IMPAX Laboratories, Inc. advising of the filing by IMPAX of an Abbreviated New Drug Application (ANDA) containing a Paragraph IV certification under 21 U.S.C. § 355(j) for oxymorphone hydrochloride extended-release tablets CII.
Ronin Technologies, Inc. (Nasdaq: RNIN) 27% LOWER; announced that it has lowered its revenue guidance for 2007. The company had previously expected 2007 sales to range from $18 million to $21 million. The company now expects 2007 sales to range from $6 million to $8 million. The consensus is $18 million.
NutriSystem, Inc. (NASDAQ: NTRI) 24% LOWER; said third Quarter 2007 revenues expected to be approximately $188 million. Earnings per diluted share expected to be between $0.62 and $0.66
Isilon Systems (Nasdaq: ISLN) 16% LOWER; said Q3 revenue is expected to be in the range of $23.2 million to $23.7 million. Previously, on the company's second quarter conference call on July 26, 2007, the company stated it expected total revenue in the range of $25 million to $27.5 million for the third quarter of 2007. The Wall Street consensus is $26.75 million. The company sees non-GAAP net loss per share to be in the range of ($0.08) to ($0.10). The Wall Street consensus is a loss of $0.03.
Wet Seal (Nasdaq: WTSLA) 13% LOWER; lowers comp and EPS guidance after the close. The company believes its change in comparable store sales for fiscal September will be in the range of -7.5% to -8.5%, as compared to -1% to +3% as previously announced. The Company also indicated that, for fiscal October, it anticipates a decrease in comparable store sales in the range of -2% to -6%. The Company now estimates for its fiscal third quarter it will report net income between $0.00 and $0.02 per diluted share compared to a prior estimate of between $0.07 and $0.10 per diluted share. Analysts' consensus
Bemis Company, Inc. (NYSE: BMS) 8.7% LOWER; announced today that, based upon preliminary performance results through September, it expects third quarter diluted earnings to be $0.37 to $0.40 per share. This is below its previous guidance range of $0.48 to $0.51 per share established in July. Consesus estimates for Q3 were $0.48. In addition, Bemis expects to further reduce its 2007 total year guidance by as much as 10% below its previous total year guidance.
Constant Contact (Nasdaq: CTCT) 7% HIGHER; Yesterday's IPO continues upside momentum after gaining 73% in its debut.
Athenahealth, Inc. (Nasdaq: ATHN) 6% HIGHER; Cramer highlights on Mad Money.
Hansen Natural Corp. (Nasdaq: HANS) 5% LOWER; Goldman Sachs downgrades from Buy to Neutral
SMART Modular Technologies (Nasdaq: SMOD) 5% LOWER; reports Q4 EPS $0.17, 3 cents lower than consensus estimates. Revenues came in at $165.6 million versus analysts estimate of $163 million. For the Q1 of fiscal 2008, SMART estimates net sales will be in the range of $165 to $175 million, gross profit will be in the range of $32 to $35 million, and diluted net income per share will be in the range of $0.17 to $0.18. Analysts' expected EPS of $0.19 in the quarter and revenue of $176.9 million. SMART currently expects fiscal 2008 diluted net income will be in the range of $0.82 to $0.86 per share. Analysts' expect '08 EPS of $0.84
Standard Pacific Corp. (NYSE: SPF) 3.5% HIGHER; UBS upgrades Standard Pacific from Sell to Neutral with a $6 price target.
i2 TECHNOLOGIES, INC. (Nasdaq: ITWO) 2.8% HIGHER; In a 13D filing, Steven Cohen's SAC Capital disclosed an 8.9% stake (1,905,806 shares) in the company. This is up from the 5.2% stake (1,106,038 shares) the firm showed in an August 13G filing. SAC said they believe that the assets, including intellectual property, tax attributes and ongoing operations, are undervalued and are not appropriately reflected in the price of the Common Stock. The firm believes that the best way for the company to increase shareholder value would be a public sale.
LDK Solar Co.Ltd. (NYSE: LDK) 2.5% LOWER; Shares of LDK fell 24.4% Wednesday following a Piper Jaffray research report discussing allegation by former Financial Controller Charley Situ of inconsistencies in LDK's inventory reporting. This morning, LDK said the allegations have no merit.
BEA Systems Inc. (Nasdaq: BEAS) 1.5% HIGHER; Carl Icahn disclosed an 13.2% stake (51,820,017 - includes Shares underlying call options) in the company. This is up from the 11% stake disclosed in a 10/03/07 filing.
Cascade Microtech, Inc. (Nasdaq: CSCD) INDICATED LOWER; sees Q3 revenue for the third quarter of 2007 is expected to be in the range of $21.4 - $21.6 million and loss per share for the third quarter is expected to be in the range of $(0.02) - $(0.04) per share. The Company previously provided guidance for the third quarter of 2007 on July 24, 2007 for revenue of $23.0 - $25.0 million and diluted earnings per share of $0.01 - $0.06. The consensus is $24.2 million and $0.07 profit, respectively.
Hollis-Eden Pharmaceuticals, Inc. (NASDAQ: HEPH) 41% HIGHER; announced positive new preclinical data with its drug candidate HE3235 for the treatment of cancer.
Penwest Pharmaceuticals Co. (Nasdaq: PPCO) 28% LOWER; the company and Endo Pharmaceuticals (Nasdaq: ENDP) received a notice from IMPAX Laboratories, Inc. advising of the filing by IMPAX of an Abbreviated New Drug Application (ANDA) containing a Paragraph IV certification under 21 U.S.C. § 355(j) for oxymorphone hydrochloride extended-release tablets CII.
Ronin Technologies, Inc. (Nasdaq: RNIN) 27% LOWER; announced that it has lowered its revenue guidance for 2007. The company had previously expected 2007 sales to range from $18 million to $21 million. The company now expects 2007 sales to range from $6 million to $8 million. The consensus is $18 million.
NutriSystem, Inc. (NASDAQ: NTRI) 24% LOWER; said third Quarter 2007 revenues expected to be approximately $188 million. Earnings per diluted share expected to be between $0.62 and $0.66
Isilon Systems (Nasdaq: ISLN) 16% LOWER; said Q3 revenue is expected to be in the range of $23.2 million to $23.7 million. Previously, on the company's second quarter conference call on July 26, 2007, the company stated it expected total revenue in the range of $25 million to $27.5 million for the third quarter of 2007. The Wall Street consensus is $26.75 million. The company sees non-GAAP net loss per share to be in the range of ($0.08) to ($0.10). The Wall Street consensus is a loss of $0.03.
Wet Seal (Nasdaq: WTSLA) 13% LOWER; lowers comp and EPS guidance after the close. The company believes its change in comparable store sales for fiscal September will be in the range of -7.5% to -8.5%, as compared to -1% to +3% as previously announced. The Company also indicated that, for fiscal October, it anticipates a decrease in comparable store sales in the range of -2% to -6%. The Company now estimates for its fiscal third quarter it will report net income between $0.00 and $0.02 per diluted share compared to a prior estimate of between $0.07 and $0.10 per diluted share. Analysts' consensus
Bemis Company, Inc. (NYSE: BMS) 8.7% LOWER; announced today that, based upon preliminary performance results through September, it expects third quarter diluted earnings to be $0.37 to $0.40 per share. This is below its previous guidance range of $0.48 to $0.51 per share established in July. Consesus estimates for Q3 were $0.48. In addition, Bemis expects to further reduce its 2007 total year guidance by as much as 10% below its previous total year guidance.
Constant Contact (Nasdaq: CTCT) 7% HIGHER; Yesterday's IPO continues upside momentum after gaining 73% in its debut.
Athenahealth, Inc. (Nasdaq: ATHN) 6% HIGHER; Cramer highlights on Mad Money.
Hansen Natural Corp. (Nasdaq: HANS) 5% LOWER; Goldman Sachs downgrades from Buy to Neutral
SMART Modular Technologies (Nasdaq: SMOD) 5% LOWER; reports Q4 EPS $0.17, 3 cents lower than consensus estimates. Revenues came in at $165.6 million versus analysts estimate of $163 million. For the Q1 of fiscal 2008, SMART estimates net sales will be in the range of $165 to $175 million, gross profit will be in the range of $32 to $35 million, and diluted net income per share will be in the range of $0.17 to $0.18. Analysts' expected EPS of $0.19 in the quarter and revenue of $176.9 million. SMART currently expects fiscal 2008 diluted net income will be in the range of $0.82 to $0.86 per share. Analysts' expect '08 EPS of $0.84
Standard Pacific Corp. (NYSE: SPF) 3.5% HIGHER; UBS upgrades Standard Pacific from Sell to Neutral with a $6 price target.
i2 TECHNOLOGIES, INC. (Nasdaq: ITWO) 2.8% HIGHER; In a 13D filing, Steven Cohen's SAC Capital disclosed an 8.9% stake (1,905,806 shares) in the company. This is up from the 5.2% stake (1,106,038 shares) the firm showed in an August 13G filing. SAC said they believe that the assets, including intellectual property, tax attributes and ongoing operations, are undervalued and are not appropriately reflected in the price of the Common Stock. The firm believes that the best way for the company to increase shareholder value would be a public sale.
LDK Solar Co.Ltd. (NYSE: LDK) 2.5% LOWER; Shares of LDK fell 24.4% Wednesday following a Piper Jaffray research report discussing allegation by former Financial Controller Charley Situ of inconsistencies in LDK's inventory reporting. This morning, LDK said the allegations have no merit.
BEA Systems Inc. (Nasdaq: BEAS) 1.5% HIGHER; Carl Icahn disclosed an 13.2% stake (51,820,017 - includes Shares underlying call options) in the company. This is up from the 11% stake disclosed in a 10/03/07 filing.
Cascade Microtech, Inc. (Nasdaq: CSCD) INDICATED LOWER; sees Q3 revenue for the third quarter of 2007 is expected to be in the range of $21.4 - $21.6 million and loss per share for the third quarter is expected to be in the range of $(0.02) - $(0.04) per share. The Company previously provided guidance for the third quarter of 2007 on July 24, 2007 for revenue of $23.0 - $25.0 million and diluted earnings per share of $0.01 - $0.06. The consensus is $24.2 million and $0.07 profit, respectively.
You May Also Be Interested In
- After-Hours Movers: QCOM, COHR, APP, HUBS, SNAP, FSLY, FIG, ZG, BROS, CDE
- Dutch Bros plummets on slowing sales, cut EBITDA outlook
- Blackbaud’s AI fundraising agent sees gifts jump 70% as adoption grows
Create E-mail Alert Related Categories
General News, Special ReportsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share